SCHEMBL26885174

SCHEMBL26885174

CC(C)NC(=O)c1ccc2cc(C(=O)O)ccc2c1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.56
XDH P47989 1/20 0.54
HPGDS O60760 1/20 0.51
IP6K1 Q92551 1/20 0.50
IP6K3 Q96PC2 1/20 0.50
IP6K2 Q9UHH9 1/20 0.50
CYP17A1 P05093 2/20 0.49
CYP3A4 P08684 1/20 0.49
GRIN2D O15399 1/20 0.49
GRIN2A Q12879 1/20 0.49
GRIN2B Q13224 1/20 0.49
GRIN2C Q14957 1/20 0.49
MLYCD O95822 1/20 0.49
NPSR1 Q6W5P4 1/20 0.47
PTPN11 Q06124 1/20 0.47
KMT2A Q03164 1/20 0.46
ALDH1A1 P00352 2/20 0.45
NR1H4 Q96RI1 1/20 0.45
LMNA P02545 1/20 0.45
CYP1A2 P05177 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26887210 0.95 XDH (0.52) KDM4EXDHHPGDSIP6K1IP6K3
SCHEMBL7477122 0.86 NPC1 (0.56) KDM4ENPSR1KMT2AALDH1A1
SCHEMBL10076788 0.86 PLAU (0.60) HPGDSCYP17A1CYP3A4MLYCDNPSR1
SCHEMBL3030047 0.86 HPGDS (0.51) HPGDSCYP17A1CYP3A4MLYCDNPSR1
SCHEMBL26885171 0.84 HPGDS (0.50) HPGDSCYP17A1CYP3A4MLYCDNPSR1
SCHEMBL26885173 0.84 PTPN11 (0.62) KDM4EXDHHPGDSCYP17A1CYP3A4
SCHEMBL3454168 0.84 PLAU (0.57) HPGDSCYP17A1CYP3A4MLYCDNPSR1
SCHEMBL26885074 0.84 CYP2A6 (0.51) HPGDSCYP17A1CYP3A4MLYCDNPSR1
SCHEMBL14355565 0.84 NPSR1 (0.61) XDHIP6K1IP6K3IP6K2CYP3A4
SCHEMBL26885181 0.83 PRMT1 (0.54) KDM4EXDHHPGDSIP6K1IP6K3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230381159-A1 SMALL MOLECULE INHIBITORS OF CORONAVIRUS ATTACHMENT AND ENTRY, METHODS AND USES THEREOF UNIVERSITY OF MIAMI 2023-11-30 US disclosed
US-20230381159-A1 SMALL MOLECULE INHIBITORS OF CORONAVIRUS ATTACHMENT AND ENTRY, METHODS AND USES THEREOF UNIVERSITY OF MIAMI 2023-11-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230381159-A1 SMALL MOLECULE INHIBITORS OF CORONAVIRUS ATTACHMENT AND ENTRY, METHODS AND USES THEREOF ACE2, ACE, SARS1 KDM4E 3581/4885XDH 2271/4885HPGDS 1783/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.